Puntos para una lectura rápida
- •
En la prevención es crucial la adopción de estilos de vida saludables.
- •
La prueba diagnóstica de elección es la ecografía abdominal, aunque en situación de urgencia puede ser la TC.
- •
La colelitiasis asintomática no requiere tratamiento ni controles excepto litiasis>3cm, pólipos>1cm, litiasis múltiple o vesícula de porcelana.
- •
El tratamiento de elección de la litiasis biliar sintomática es la colecistectomía laparoscópica excepto en pacientes con contraindicación quirúrgica.
- •
El tratamiento con ácido ursodesoxicólico solo se recomienda en casos seleccionados.
Palabras clave
Litiasis biliar,Actualización
Diagnóstico
Tratamiento
Atención Primaria
Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1]
I.J. Beckingham.
Elsevier Ltd, (2023), pp. 453-456
[2]
P. Cianci, E. Restini.
Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches.
World J Gastroenterol [Internet]., (2021), 27 pp. 4536-4554
[3]
European Association for the Study of the Liver (EASL).
Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.
J Hepatol [Internet]., (2016), 65 pp. 146-181
[4]
C. Corpechot, A. Pariente.
Litiasis biliar.
EMC - Tratado de Medicina., (2024), 28 pp. 1-10
[5]
L.M. Stinton, E.A. Shaffer.
Epidemiology of gallbladder disease: Cholelithiasis and cancer.
Gut and Liver., (2012), 6 pp. 172-187
[6]
M. Möller, U. Gustafsson, F. Rasmussen, G. Persson, A. Thorell.
Natural Course vs Interventions to Clear Common Bile Duct Stones.
JAMA Surg [Internet]., (2014), 149 pp. 1008
[7]
C. Gutt, S. Schläfer, F. Lammert.
The treatment of gallstone disease.
Dtsch Arztebl Int., (2020), 117 pp. 148-158
[8]
Otero IP, Cavero CI, Flores-Fernández V, Gómez AD. Litiasis biliar. Medicine - Programa de Formación Médica Continuada Acreditado [Internet]. 2024 Apr 1 [citada 16 Nov 2024];14(7):371-8. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0304541224000891.
[9]
M. Pak, G. Lindseth.
Risk factors for cholelithiasis.
Gastroenterology Nursing., (2016), 39 pp. 297-309
[10]
D.M. Shabanzadeh, S. Novovic.
Alcohol, smoking and benign hepato-biliary disease.
Best Pract Res Clin Gastroenterol., (2017), 31 pp. 519-527
[11]
D. Aune, L.J. Vatten, P. Boffetta.
Tobacco smoking and the risk of gallbladder disease.
Eur J Epidemiol., (2016), 31 pp. 643-653
[12]
Y.S. Choi, B. Cha, S.H. Kim, J.W. Yi, K.D. Kim, M.S. Choi, et al.
Clinical Characteristics of Symptomatic Cholecystitis in Post-Gastrectomy Patients: 11 Years of Experience in a Single Center.
Medicina (Lithuania)., (2022), 58
[13]
L. He, J. Wang, F. Ping, N. Yang, J. Huang, W. Li, et al.
Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials.
BMJ., (2022), 377 pp. e068882
[14]
L. He, J. Wang, F. Ping, N. Yang, J. Huang, Y. Li, et al.
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
JAMA Intern Med., (2022), 182 pp. 513-519
[15]
I. Rodríguez-Antonio, G.N. López-Sánchez, V.Y. Garrido-Camacho, M. Uribe, N.C. Chávez-Tapia, N. Nuño-Lámbarri.
Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development.
HPB., (2020), 22 pp. 1513-1520
[16]
C.S.S. Latenstein, P.R. de Reuver.
Tailoring diagnosis and treatment in symptomatic gallstone disease.
British J of Surgery [Internet]., (16 Aug 2022), 109 pp. 832-838
[17]
A.E. Liepert, M. Ancheta, E. Williamson.
Management of Gallstone Disease.
Surgical Clinics of North America [Internet], (2024), 104 pp. 1159-1173
[18]
S.A. Politano, N. Hamiduzzaman, D. Alhaqqan.
Diseases of the Gallbladder and Biliary Tree.
Primary Care: Clinics in Office Practice [Internet]., (2023), 50 pp. 377-390
[19]
J.R. Gallaher, A. Charles.
Acute Cholecystitis.
JAMA [Internet]., (2022), 327 pp. 965
[20]
M. Yokoe, J. Hata, T. Takada, S.M. Strasberg, H.J. Asbun, G. Wakabayashi, et al.
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos).
J Hepatobiliary Pancreat Sci [Internet]., (2018), 25 pp. 41-54
[21]
F. Miura, K. Okamoto, T. Takada, S.M. Strasberg, H.J. Asbun, H.A. Pitt, et al.
Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis.
J Hepatobiliary Pancreat Sci [Internet]., (2018), 25 pp. 31-40
[22]
K.S. Gurusamy, V. Giljaca, Y. Takwoingi, D. Higgie, G. Poropat, D. Štimac, et al.
Ultrasound versus liver function tests for diagnosis of common bile duct stones.
Cochrane Database of Systematic Reviews [Internet]., (2015), 2015
[23]
M.H. Yang, T.H. Chen, S.E. Wang, Y.F. Tsai, C.H. Su, C.W. Wu, et al.
Biochemical predictors for absence of common bile duct stones in patients undergoing laparoscopic cholecystectomy.
Surg Endosc [Internet]., (2008), 22 pp. 1620-1624
[24]
M. Ross, M. Brown, K. McLaughlin, P. Atkinson, J. Thompson, S. Powelson, et al.
Emergency physician-performed ultrasound to diagnose cholelithiasis: a systematic review.
Acad Emerg Med [Internet]., (2011), 18 pp. 227-235
[25]
F. Lammert, K. Gurusamy, C.W. Ko, J.F. Miquel, N. Méndez-Sánchez, P. Portincasa, et al.
Gallstones.
Nat Rev Dis Primers [Internet]., (2016), 2 pp. 16024
[26]
P. Portincasa, A. Di Ciaula, O. de Bari, G. Garruti, V. Palmieri, D.H. Wang.
Management of gallstones and its related complications.
Expert Rev Gastroenterol Hepatol [Internet]., (2016), 10 pp. 93-112
[27]
A. Mulliri, B. Menahem, A. Alves, B. Dupont.
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
J Gastroenterol [Internet]., (2022), 57 pp. 529-539
[28]
S. Tazuma, M. Unno, Y. Igarashi, K. Inui, K. Uchiyama, M. Kai, et al.
Evidence-based clinical practice guidelines for cholelithiasis 2016.
J Gastroenterol. [Internet]., (2017), 52 pp. 276-300
[29]
M. Fraquelli, G. Casazza, D. Conte, A. Colli.
Non-steroid anti-inflammatory drugs for biliary colic.
Cochrane Database of Systematic Reviews [Internet], (2016), 2016
[30]
J.L. Buxbaum, S.M. Abbas Fehmi, S. Sultan, D.S. Fishman, B.J. Qumseya, V.K. Cortessis, et al.
ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis.
Gastrointest Endosc., (2019), 89
[31]
M.P. Lamberts.
Indications of cholecystectomy in gallstone disease.
Curr Opin Gastroenterol [Internet]., (2018), 34 pp. 97-102
[32]
J.M. Schofer.
Biliary Causes of Postcholecystectomy Syndrome.
J Emerg Med [Internet]., (2010), 39 pp. 406-410
[33]
A. Farrugia, J.A. Attard, S. Khan, N. Williams, R. Arasaradnam.
Postcholecystectomy diarrhoea rate and predictive factors: A systematic review of the literature.
BMJ Open, (2022), 12
[34]
D.C. Sadowski, M. Camilleri, W.D. Chey, G.I. Leontiadis, J.K. Marshall, E.A. Shaffer, et al.
Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea.
Clin Gastroenterol Hepatol., (2020), 18
[35]
K. Okamoto, K. Suzuki, T. Takada, S.M. Strasberg, H.J. Asbun, I. Endo, et al.
Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.
J Hepatobiliary Pancreat Sci [Internet]., (2018 Jan 20), 25 pp. 55-72
[36]
N. Sun, X. Wang, J. Wei.
Gallstones, cholecystectomy and the risk of pancreatic cancer: An updated systematic review and meta-analysis of cohort studies.
Eur J Gastroenterol Hepatol. Lippincott Williams and Wilkins, (2023), 35 pp. 1313-1323
